Intelligence · Clinical Development
Pipeline search results
Programs matching “asthma” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 226 pipeline programs matching "asthma" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Albuterol eMDPI DS
Teva Pharma GmbH
Asthma
1 trial -
Albuterol-HFA-MDI
Teva Pharma GmbH
Asthma
1 trial -
Beclomethasone (QVAR)
Teva Pharma GmbH
Asthma
1 trial -
Budesonide 200 microgram/Puff, HFA MDI
The First People's Hospital of Lianyungang
Asthma
1 trial -
CLI-05993AB1-08
Chiesi Farmaceutici S.p.A
Asthma
1 trial -
D3250C00059
AstraZeneca AB
Severe eosinophilic asthma
1 trial -
Dupilumab
Regeneron UK Limited
Asthma
13 trials -
Dupilumab
Sanofi Pasteur
Asthma
2 trials -
Dupilumab Injectable Product
Regeneron UK Limited
Asthma
1 trial -
Fluticasone propionate/salmeterol (FS)
Teva Pharma GmbH
Asthma
1 trial -
ICS/LABA
The First People's Hospital of Lianyungang
Asthma
1 trial -
LPS16676
Sanofi-aventis Healthcare Pty Ltd
Asthma
1 trial -
Procaterol
Otsuka Beijing Research Institute
Asthma
1 trial -
Qvar
Teva Pharma GmbH
Asthma
2 trials -
Qvar® (beclometasone dipropionate HFA)
Teva Pharma GmbH
Asthma
1 trial -
R668-AS-2373
Lacuna Pharma Pty Ltd
Asthma
1 trial -
Reslizumab
Teva Pharma GmbH
Asthma
5 trials -
Reslizumab
Teva Pharma GmbH
Asthma; Eosinophilic
1 trial -
SAR231893
Regeneron UK Limited
Asthma
1 trial -
Salmeterol/fluticasone propionate or formoterol/budesonide
GlaxoSmithKline
Asthma
1 trial -
Symbicort Turbuhaler 160/4.5
AstraZeneca
Asthma
1 trial -
Test preparation：Methylcholine chloroacetate for inhalation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Asthma
1 trial -
Xolair 75 mg solution for injection in pre-filled syringe
Pari Pharma GmbH
Well controlled severe allergic asthma
1 trial -
Zithromax
United Therapeutics Europe Ltd
Asthma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.